Herpes Simplex Virus Type 2 Antibodies: High Prevalence in Monogamous Women in Costa Rica

Mark W. OberleU.S. Department of Health and Human Services, Centers for Disease Control, University of Costa Rica, Emory University, Atlanta, Georgia

Search for other papers by Mark W. Oberle in
Current site
Google Scholar
PubMed
Close
,
Luis Rosero-BixbyU.S. Department of Health and Human Services, Centers for Disease Control, University of Costa Rica, Emory University, Atlanta, Georgia

Search for other papers by Luis Rosero-Bixby in
Current site
Google Scholar
PubMed
Close
,
Francis K. LeeU.S. Department of Health and Human Services, Centers for Disease Control, University of Costa Rica, Emory University, Atlanta, Georgia

Search for other papers by Francis K. Lee in
Current site
Google Scholar
PubMed
Close
,
Maria Sanchez-BravermanU.S. Department of Health and Human Services, Centers for Disease Control, University of Costa Rica, Emory University, Atlanta, Georgia

Search for other papers by Maria Sanchez-Braverman in
Current site
Google Scholar
PubMed
Close
,
Andre J. NahmiasU.S. Department of Health and Human Services, Centers for Disease Control, University of Costa Rica, Emory University, Atlanta, Georgia

Search for other papers by Andre J. Nahmias in
Current site
Google Scholar
PubMed
Close
, and
Mary E. GuinanU.S. Department of Health and Human Services, Centers for Disease Control, University of Costa Rica, Emory University, Atlanta, Georgia

Search for other papers by Mary E. Guinan in
Current site
Google Scholar
PubMed
Close
Restricted access

We studied the prevalence of antibody to Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in 766 randomly selected Costa Rican women 25–59 years of age in a national household survey in 1984–1985. Overall, 97.1% were seropositive for HSV-1 and 39.4% for HSV-2. Only 1.1% of HSV-2 seropositive women gave a history of symptomatic genital herpes. HSV-2 virus antibody increased with age and with the number of lifetime sexual partners. HSV-2 seroprevalence among women who reported only 1 lifetime sexual partner was almost twice as high as the prevalence among women who denied sexual experience (30.5% vs. 17.7%) and reached 79.2% among women with ≥4 partners. HSV-2 seroprevalence was lower among women whose partners used condoms: 28.9% for those who had used condoms for at least 2 years vs. 44.3% for those who never used condoms.

Save